All lobbying filings

OGR

OGR filed a Q3 report for AMNEAL PHARMACEUTICALS LLC on October 19, 2025, reporting $20,000 in lobbying income.

Lobbying for AMNEAL PHARMACEUTICALS LLC · pharmaceuticals company

All filings by OGR · Everything AMNEAL PHARMACEUTICALS LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Manufacturing

Advocate for the importance of maintaining strong domestic manufacturing industry; H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026.

Bills named in this filing 2

H.R. 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S. 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.